Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly interrupted when a drug executive fainted while President Donald Trump announced a deal with pharmaceutical companies to lower drug prices.
Incident Details
The event, held on Thursday, involved a joint announcement by President Trump and drugmakers Eli Lilly and Novo Nordisk about expanding coverage and reducing costs for their obesity treatments, Zepbound and Wegovy.
David Ricks, CEO of Eli Lilly, noticed the executive collapsing and asked,
“Are you okay? Gordon, are you okay?”
Response and Key Figures
The man who collapsed was identified as Gordon Findlay, the global brand director for Novo Nordisk. Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, quickly assisted as Findlay fell to his knees.
Health and Human Services Secretary was also present during the incident. The press was promptly escorted out of the room following the event.
Aftermath
About 30 minutes after the interruption, the press conference resumed and President Trump provided an update on Findlay’s condition.
“President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help Gordon Findlay.”
Author's summary: During a White House press briefing on drug price reductions, Novo Nordisk's Gordon Findlay fainted, with quick aid from Dr. Mehmet Oz and a brief pause before the event resumed.
Would you like me to format this for a specific website or publication?